One paper
by ScitoVation authors
-
BR Starling,
P Kumar,
AT Lucas,
D Barrow,
L Farnan,
L Hendrix,
H Giovinazzo,
G Song,
P Gehrig,
JT Bensen,
and
WC Zamboni.
Mononuclear phagocyte system function and nanoparticle pharmacology in obese and normal weight ovarian and endometrial cancer patients.
Cancer Chemother Pharmacol
83
(1)
: 61-70
(Jan 16, 2019).
[abstract]
[pubmed]
Obesity may alter mononuclear phagocyte system (MPS) function and the pharmacology and efficacy of nanoparticles therapies, such as PEGylated liposomal doxorubicin (PLD). We aimed to evaluate the relationships between hormone and chemokine mediators of MPS function and the pharmacokinetic (PK) exposure of PLD in obese and normal weight patients with ovarian and endometrial cancer.